Trade Mark Journal No.2025/046 14 November 2025

WO0000001883772 (5,42)

Office of origin: United States of America

Date of International Registration:2 October 2025
Date of designation in the UK: 2 October 2025
Image for mark 1883772 BBOT

International priority date claimed: 1 May 2025 (United States of America) (99166265)
Class 5
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.
Class 42
Pharmaceutical research and development services; providing scientific research information in the field of pharmaceuticals and clinical trials; drug discovery services, namely, providing a drug discovery platform being programming for the research and development of pharmaceuticals and therapeutics.

TheRas, Inc.

Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA